Ligand profile
IW8
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3566 — ankyrin repeat family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
IW8- PDB
4tor- UniProt (similar protein)
O95271- Target protein
- VK055_3566
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 79.7
- −1 ≤ LogP ≤ 5 4.83
- MW ≤ 500 Da 546.5
- LogP ≤ 5 4.83
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 79.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCN(c1cccc(c1)C)C(=O)C2CCN(CC2)S(=O)(=O)c3cc4c(ccn4C(=O)C)cc3BrCCN(c1cccc(c1)C)C(=O)C2CCN(CC2)S(=O)(=O)c3cc4c(ccn4C(=O)C)cc3Br
InChI=1S/C25H28BrN3O4S/c1-4-28(21-7-5-6-17(2)14-21)25(31)19-8-11-27(12-9-19)34(32,33)24-16-23-20(15-22(24)26)10-13-29(23)18(3)30/h5-7,10,13-16,19H,4,8-9,11-12H2,1-3H3InChI=1S/C25H28BrN3O4S/c1-4-28(21-7-5-6-17(2)14-21)25(31)19-8-11-27(12-9-19)34(32,33)24-16-23-20(15-22(24)26)10-13-29(23)18(3)30/h5-7,10,13-16,19H,4,8-9,11-12H2,1-3H3
PCDHUAUNNCKKQB-UHFFFAOYSA-NPCDHUAUNNCKKQB-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00644
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand IW8 →
- PDB RCSB structure 4tor →
- UniProt UniProt O95271 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “IW8”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3566.
PDB 124
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).